David B.

David B. has extensive experience in the pharmaceutical and research industry. David is currently the Founder, Director, and CSO at Rapport Therapeutics. Previously, they worked at Johnson & Johnson as the Global Head of Discovery Neuroscience, where they led the Global Neuroscience Discovery biology and chemistry teams and was responsible for the discovery and translational development of biomarkers. Prior to that, David served as the Vice President of Neuroscience Discovery and Clinical Research at Eli Lilly, overseeing the discovery and clinical development activities for the company's global Neuroscience portfolio. David also worked at UCSF as a Professor of Physiology, where they directed molecular neuroscience research.

David B. attended Princeton University from 1982 to 1986, where they obtained their A.B. degree in Chemistry. David then attended The Johns Hopkins University School of Medicine from 1986 to 1993, earning both their M.D. and Ph.D. degrees. Their field of study at The Johns Hopkins University School of Medicine was Medicine and Pharmacology.